| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.06 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |